These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Treatment of invasive fungal diseases in cancer patients-Revised 2019 Recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Ruhnke M; Cornely OA; Schmidt-Hieber M; Alakel N; Boell B; Buchheidt D; Christopeit M; Hasenkamp J; Heinz WJ; Hentrich M; Karthaus M; Koldehoff M; Maschmeyer G; Panse J; Penack O; Schleicher J; Teschner D; Ullmann AJ; Vehreschild M; von Lilienfeld-Toal M; Weissinger F; Schwartz S Mycoses; 2020 Jul; 63(7):653-682. PubMed ID: 32236989 [TBL] [Abstract][Full Text] [Related]
24. Frequency and Determinants of Invasive Fungal Infections in Children With Solid and Hematologic Malignancies in a Nonallogeneic Stem Cell Transplantation Setting: A Narrative Review. Ruijters VJ; Oosterom N; Wolfs TFW; van den Heuvel-Eibrink MM; van Grotel M J Pediatr Hematol Oncol; 2019 Jul; 41(5):345-354. PubMed ID: 30973485 [TBL] [Abstract][Full Text] [Related]
25. Clinical risk score for predicting invasive fungal disease after allogeneic hematopoietic stem cell transplantation: Analysis of the China Assessment of Antifungal Therapy in Hematological Diseases (CAESAR) study. Sun Y; Hu J; Huang H; Chen J; Li J; Ma J; Li J; Liang Y; Wang J; Li Y; Yu K; Hu J; Jin J; Wang C; Wu D; Xiao Y; Huang X Transpl Infect Dis; 2021 Aug; 23(4):e13611. PubMed ID: 33825274 [TBL] [Abstract][Full Text] [Related]
26. A consensus document for the clinical management of invasive fungal diseases in pediatric patients with hematologic cancer and/or undergoing hematopoietic stem cell transplantation in Brazilian medical centers. Carlesse F; Daudt LE; Seber A; Dutra ÁP; Melo ASA; Simões B; Macedo CRD; Bonfim C; Benites E; Gregianin L; Batista MV; Abramczyk M; Tostes V; Lederman HM; Lee MLM; Loggetto S; Galvão de Castro Junior C; Colombo AL Braz J Infect Dis; 2019; 23(6):395-409. PubMed ID: 31738887 [TBL] [Abstract][Full Text] [Related]
27. Parasitic Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient, Including Toxoplasmosis and Strongyloidiasis. Peixoto D; Prestes DP Infect Dis Clin North Am; 2019 Jun; 33(2):567-591. PubMed ID: 31005139 [TBL] [Abstract][Full Text] [Related]
28. Risk Factors and Outcomes of Invasive Fungal Infections in Allogeneic Hematopoietic Cell Transplant Recipients. Miceli MH; Churay T; Braun T; Kauffman CA; Couriel DR Mycopathologia; 2017 Jun; 182(5-6):495-504. PubMed ID: 28124219 [TBL] [Abstract][Full Text] [Related]
29. Risk Factors for Invasive Mold Infections and Implications for Choice of Prophylaxis after Allogeneic Stem Cell Transplantation. Blennow O; Remberger M; Törlén J; Szakos A; Ljungman P; Mattsson J Biol Blood Marrow Transplant; 2016 Sep; 22(9):1684-1689. PubMed ID: 27311967 [TBL] [Abstract][Full Text] [Related]
30. Epidemiology and Factors Associated with Treatment Success of Invasive Fungal Infections Among Newly Hematologic Malignancy Patients Receiving Chemotherapy or Hematopoietic Stem Cell Transplant in Thailand. Weeraphon B; Nakaranurack C; Jutivorakool K; Puttilerpong C Infect Drug Resist; 2023; 16():2029-2042. PubMed ID: 37041985 [TBL] [Abstract][Full Text] [Related]
31. Antifungal prophylaxis in haematology patients: the role of voriconazole. Hicheri Y; Cook G; Cordonnier C Clin Microbiol Infect; 2012 Apr; 18 Suppl 2():1-15. PubMed ID: 22409648 [TBL] [Abstract][Full Text] [Related]
32. [Invasive aspergillosis in the patient with oncohematologic disease]. Solano C; Vázquez L Rev Iberoam Micol; 2018; 35(4):198-205. PubMed ID: 30554673 [TBL] [Abstract][Full Text] [Related]
33. Invasive fungal infections: managing the continuum of risk in HCT patients. Duarte RF; Lyon S Future Microbiol; 2017 Aug; 12():843-846. PubMed ID: 28685597 [TBL] [Abstract][Full Text] [Related]
34. ECIL-6 guidelines for the treatment of invasive candidiasis, aspergillosis and mucormycosis in leukemia and hematopoietic stem cell transplant patients. Tissot F; Agrawal S; Pagano L; Petrikkos G; Groll AH; Skiada A; Lass-Flörl C; Calandra T; Viscoli C; Herbrecht R Haematologica; 2017 Mar; 102(3):433-444. PubMed ID: 28011902 [TBL] [Abstract][Full Text] [Related]
35. Invasive Fungal Infections in Patients with Hematological Malignancies: Emergence of Resistant Pathogens and New Antifungal Therapies. Gamaletsou MN; Walsh TJ; Sipsas NV Turk J Haematol; 2018 Mar; 35(1):1-11. PubMed ID: 29391334 [TBL] [Abstract][Full Text] [Related]
36. Invasive Fungal Pneumonia in Immunocompromised Patients. Godoy MCB; Ferreira Dalla Pria HR; Truong MT; Shroff GS; Marom EM Radiol Clin North Am; 2022 May; 60(3):497-506. PubMed ID: 35534133 [TBL] [Abstract][Full Text] [Related]
37. Randomized trial of micafungin versus fluconazole as prophylaxis against invasive fungal infections in hematopoietic stem cell transplant recipients. Park S; Kim K; Jang JH; Kim SJ; Kim WS; Chung DR; Kang CI; Peck KR; Jung CW J Infect; 2016 Nov; 73(5):496-505. PubMed ID: 27394404 [TBL] [Abstract][Full Text] [Related]